Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2024
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Parcel Pick Up
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
GH Research PLC - Ordinary Shares
(NQ:
GHRS
)
11.00
+0.12 (+1.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about GH Research PLC - Ordinary Shares
GH Research Reports Full Year 2024 Financial Results and Provides Business Updates
February 27, 2025
From
GH Research PLC
Via
GlobeNewswire
GH Research Announces Pricing of $150 Million Public Offering
February 04, 2025
From
GH Research PLC
Via
GlobeNewswire
GH Research Announces Proposed Public Offering
February 03, 2025
From
GH Research PLC
Via
GlobeNewswire
GH Research Announces Primary Endpoint Met in Phase 2b Trial with GH001 in TRD Demonstrating -15.5 Point Placebo-adjusted MADRS Reduction
February 03, 2025
From
GH Research PLC
Via
GlobeNewswire
GH Research to Provide Update on Phase 2b Trial with GH001 in TRD
January 31, 2025
From
GH Research PLC
Via
GlobeNewswire
GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents
January 10, 2025
From
GH Research PLC
Via
GlobeNewswire
GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 14, 2024
From
GH Research PLC
Via
GlobeNewswire
GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates
September 03, 2024
From
GH Research PLC
Via
GlobeNewswire
GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer
September 03, 2024
From
GH Research PLC
Via
GlobeNewswire
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
May 03, 2024
From
GH Research PLC
Via
GlobeNewswire
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
February 29, 2024
From
GH Research PLC
Via
GlobeNewswire
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
January 18, 2024
From
GH Research PLC
Via
GlobeNewswire
GH Research Reports Third Quarter Financial Results and Provides Business Updates
November 09, 2023
From
GH Research PLC
Via
GlobeNewswire
GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression
September 29, 2023
From
GH Research PLC
Via
GlobeNewswire
GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 23, 2023
From
GH Research PLC
Via
GlobeNewswire
GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights
May 11, 2023
From
GH Research PLC
Via
GlobeNewswire
GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
March 02, 2023
From
GH Research PLC
Via
GlobeNewswire
GH Research Provides Business Updates and Highlights Key Upcoming Milestones
January 09, 2023
From
GH Research PLC
Via
GlobeNewswire
GH Research Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 10, 2022
From
GH Research PLC
Via
GlobeNewswire
NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Differentiates Itself in Psychedelics Space
March 07, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
NetworkNewsWire Editorial Coverage New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of...
Via
FinancialNewsMedia
Top Ideas in the Small Cap Biotech Space (LEXTF, ABBV, SAVA, SNDL, RETA, PAHC)
January 24, 2022
Via
AB Newswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.